Though the start of 2018 was tinged with uncertainty over changes in the global healthcare market and the fate of Obamacare’s medical device tax, the industry appears to be heading down a familiar path in its annual M&A jaunt. Reflecting on Q1, OEM and contract manufacturing consolidation look to be on a similar pace to last year’s record as M&A deals continue to flourish.
Take a look at Mark Bonifacio’s recent article for MPO magazine to learn more about what’s happened so far in 2018, and what may be in store for the second half of the year.